ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Clinical Osteoporosis"

  • Abstract Number: 1323 • ACR Convergence 2022

    Secondary Prevention of Vertebral Fractures Sustained Efficacy over Time

    JOSE ELOY OLLER RODRIGUEZ1, Elena Grau García2, Samuel Leal Rodriguez3, Laura Mas Sanchez2, Pablo Francisco Muñoz Martínez4, Carmen Riesco Bárcena5, Anderson Huaylla Quispe6, Cristobal Pavez Perales2, Francisco Miguel Ortiz Sanjuan7, José Ivorra Cortés2, Inés Cánovas Olmos2, Luis González Puig8, Isabel Martínez-Cordellat2, Carmen Nájera Herranz7, Rosa Negueroles Albuixech2, Elvira Vicens Bernabeu7, Alba Torrat Novés5, Daniel Ramos Castro2 and José andrés Román ivorra3, 1Hospital Universitario de La Fe, València, Spain, 2Rheumatology Department. Hospital Universitario y Politécnico La Fe, València, Spain, 3Hospital Universitari i Politécnic La Fe, València, Spain, 4Hospital Universitario y Politécnico La Fe, València, Spain, 5Rheumatology Department. Hospital Universitario y Politécnico La Fe, València, 6Medicina, València, Spain, 7Hospital Universitario de La Fe, València, 8Rheumatology Department. Hospital Universitario y Politécnico La Fe, Torrente, Valencia, Spain

    Background/Purpose: Vertebral fractures entail a notorious social and health problem, and their presence is the greatest risk factor for the appearance of a new vertebral…
  • Abstract Number: 1324 • ACR Convergence 2022

    Treatment Patterns in Women with Post-Menopausal Osteoporosis Using Abaloparatide: A Real-world Observational Study

    Deborah Gold1, Tammy Beckett2, Chad Deal3, Andrew L James4, Jacqueline M Kernaghan5, Mahshid Mohseni6, Abigail McMillan7, Tom Bailey7, Leny Pearman8, John Caminis8, Yamei Wang8 and Setareh A Williams9, 1Duke University Medical Center, Durham, NC, 2Department of Orthopaedics, Orthopaedic Associates of Grand Rapids Research and Education Institute, Grand Rapids, MI, 3Cleveland Clinic, Shaker Heights, OH, 4Columbia Orthopaedic Groups LLP, Columbia, MO, 5Prospect Health Access Network, Springfield, PA, 6Washington University School of Medicine, St. Louis, MO, 7Observational Research Adelphi Real World, Macclesfield, United Kingdom, 8Radius Health, Inc., Waltham, MA, 9CobbsCreek Healthcare, Newtown Square, PA

    Background/Purpose: Abaloparatide (ABL) is approved for treatment of women with postmenopausal osteoporosis (PMO) at high risk for fracture. The study evaluated real-world treatment patterns for…
  • Abstract Number: 0070 • ACR Convergence 2022

    Post-operative Delirium and Cognitive Impairment: An Analysis of Predictors and 120-day Outcomes in England Using the National Hip Fracture Database (NHFD)

    Samuel Hawley1, Dominic Inman2, Celia Gregson1, Michael Whitehouse1, Antony Johansen3 and Andrew Judge1, 1University of Bristol, Bristol, United Kingdom, 2Northumbria Healthcare NHS Foundation Trust, Northumbria, United Kingdom, 3Cardiff University, Cardiff, Wales, United Kingdom

    Background/Purpose: Post-operative delirium and cognitive impairment are common after hip fracture. We set out to identify risk factors and examine the association with returning home…
  • Abstract Number: 1314 • ACR Convergence 2022

    Response Rates for Lumbar Spine, Total Hip, and Femoral Neck Bone Mineral Density with Abaloparatide in Men: Results from the ATOM Study

    Ruban Dhaliwal1, David Kendler2, Kenneth Saag3, Steven Ing4, Andrea Singer5, Robert Adler6, Leny Pearman7, Yamei Wang7 and Bruce Mitlak8, 1SUNY Upstate Medical University, Syracuse, NY, 2University of British Columbia, Vancouver, BC, Canada, 3University of Alabama at Birmingham, Birmingham, AL, 4Ohio State University Wexner Medical Center, Colombus, OH, 5MedStar Georgetown University Hospital, Washington, DC, 6Hunter Holmes McGuire Veterans Affairs Medical Center-Richmond, Richmond, VA, 7Radius Health, Inc., Waltham, MA, 8Radius Health, Inc, Boston, MA

    Background/Purpose: In the Abaloparatide for the Treatment of Men with Osteoporosis (ATOM) study, 12 months of abaloparatide therapy resulted in rapid and significant improvements in…
  • Abstract Number: 1322 • ACR Convergence 2022

    Follow up of Incidentally Noted Vertebral Compression Fractures

    Jason Yang1, Alexia Hwang1, Megan Brochu2, Krista Sabina2, Meridith Malysz2, Bruce Weinstein3 and Jonathan Cheah1, 1UMass Chan Medical School, Worcester, MA, 2UMass Memorial Health, Worcester, MA, 3UMass Memorial Health, UMass Chan Medical School, Worcester, MA

    Background/Purpose: Vertebral compression fractures (VCFs) in general represent a clinical diagnosis of osteoporosis, predisposing to an increased risk of additional fractures. However, a significant number…
  • Abstract Number: 0445 • ACR Convergence 2021

    Safety and Efficacy of Denosumab vs Risedronate in Patients with Glucocorticoid-Induced Osteoporosis and Rheumatoid Arthritis

    Jonathan Adachi1, Arkadi Chines2, Shuang Huang2, Kenneth Saag3, Willem Lems4 and Piet Geusens5, 1McMaster University/St. Joseph's Healthcare, Hamilton, ON, Canada, 2Amgen Inc., Thousand Oaks, CA, 3University of Alabama at Birmingham, Birmingham, AL, 4VUmc, Amsterdam, Netherlands, 5Maastricht University, Genk, Belgium

    Background/Purpose: Denosumab (DMAb) is approved for the treatment of glucocorticoid (GC)–induced osteoporosis (GiOP). In a phase 3, international, active-controlled, double-blind, double-dummy study, treatment with DMAb…
  • Abstract Number: 1136 • ACR Convergence 2021

    Risk of Osteoporosis in Patients with Systemic Sclerosis: A Cross-Sectional Analysis of Two European Prospective Cohorts

    Charles Midol1, Edgar Wiebe2, Elise Siegert2, Dörte Huscher3, David Launay4, Eric Hachulla4, Vincent Sobanski1 and Frank Buttgereit5, 1Univ. Lille, Inserm, CHU Lille, Service de Médecine Interne, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000 Lille, France, Lille, France, 2Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Germany, Berlin, Germany, 3Institute of Biometry and Clinical Epidemiology, and Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Berlin, Germany, 4Univ. Lille, Inserm, CHU Lille, Service de Médecine Interne, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000 Lille, France, Lille Cedex, France, 5Charité – Universitätsmedizin Berlin, Berlin, Germany

    Background/Purpose: Patients with systemic sclerosis (SSc) are at high risk for osteoporosis (OPO) and fragility fractures, although their exact prevalences are unknown. This might be…
  • Abstract Number: 1139 • ACR Convergence 2021

    Fracture Liaison Service Outcomes at a Southern California County Hospital Highlights Need for Health System Improvements

    Muntarin Karim1, lorien ahn2, Jordan Thompson1, Christina Downey3, Lorena Salto4 and Karina Torralba5, 1Loma Linda University, Redlands, CA, 2loma linda university medical center, Loma Linda, CA, 3Loma Linda University Medical Center, Redlands, CA, 4Loma Linda University Health, Loma Linda, CA, 5Division of Rheumatology, Department of Medicine, Loma Linda University Healthcare, Loma Linda, CA

    Background/Purpose: Osteoporosis causes significant morbidity and mortality in the elderly. Despite the benefits of treatment, < 25% of elderly patients who fracture receive treatment. A…
  • Abstract Number: 1142 • ACR Convergence 2021

    For Vulnerable Population Treated at a Community Health Center (CHC), Primary Care Physician (PCP) Turnover Should Be Included in Social Determinants of Health (SDH) on Non-completing Osteoporosis Treatment

    Yu Na Kim1 and Julie Crosson2, 1DotHouse Health, Boston, 2DotHouse Health, Boston University, Boston

    Background/Purpose: Unexplained interruptions in treatment are common among patients with osteoporosis, but it is not well studied how PCP turnover affects incompletion of osteoporosis treatment…
  • Abstract Number: 1144 • ACR Convergence 2021

    Underestimation of the Fracture Risk by the FRAX Formula in Chronic Glucocorticoid Users: A 10-year Longitudinal Validation Study

    Chi Chiu Mok1, Ling Yin Ho2, Sau Mei TSE2 and Kar Li Chan3, 1Tuen Mun Hospital, Hong Kong, China, 2Tuen Mun Hospital, Hong Kong, Hong Kong, 3Tuen Mun Hospital, Hong Kong

    Background/Purpose: To compare the actual fracture incidence over 10 years in a longitudinal cohort of patients using glucocorticoids (GCs) with the risk prediction from FRAX…
  • Abstract Number: 1147 • ACR Convergence 2021

    Therapeutic Inertia and Low Patient Compliance: Major Contributors to Low Treatment Rates in Patients with Osteoporosis with Clinical Vertebral Compression Fractures

    Shiva Malaty, Paramvir Sidhu, Rustan Sharer and Soo Yeon Kim, HonorHealth Internal Medicine Residency, Scottsdale, AZ

    Background/Purpose: Treatment rates with pharmacologic therapy after osteoporotic vertebral fracture are very low in the United States. Underlying causes of these low treatment rates are…
  • Abstract Number: 1265 • ACR Convergence 2021

    Paradoxical Effect of Vitamin D on Bone Mineral Density in SLE

    Michelle Petri1, Jessica Li2 and Daniel Goldman1, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2Johns Hopkins University, Baltimore, MD

    Background/Purpose: Osteoporosis with fractures is consistently one of the top three items in the SLICC/ACR Damage Index in cohort studies internationally. As vitamin D insufficiency…
  • Abstract Number: 1304 • ACR Convergence 2021

    Increased Risk of Vertebral Fracture Among Patients with Psoriatic Arthritis: A Systematic Review and Meta-analysis

    Patompong Ungprasert1, Nipith Charoenngam2, Ben Ponvilawan3, Jerapas Thongpiya4 and Pitchaporn Yingchoncharoen3, 1Cleveland Clinic, Cleveland Heights, OH, 2Mount Auburn Hospital, Boston, MA, 3Mahidol University, Bangkok, Thailand, 4Mahdiol University, Bangkok, Thailand

    Background/Purpose: Increased risk of vertebral fracture (VF) has been documented in several autoimmune diseases as a result of excessive inflammatory burden and use of corticosteroids.…
  • Abstract Number: 0115 • ACR Convergence 2020

    Improving Osteoporosis Screening in Men at a Resident-run Primary Care Clinic: A Quality Improvement Project

    Khiem Vu1, Chima Ohadugha1, Kevin Dao1, Rabih Nayfe2 and Andrew Mangano1, 1Grand Strand Medical Center, Myrtle Beach, SC, 2Carolina Health Specialists - Rheumatology, Myrtle Beach, SC

    Background/Purpose: There are known indications for osteoporosis screening in women. However, osteoporosis also occurs in men and fragility fractures are linked to increased morbidity and…
  • Abstract Number: 0119 • ACR Convergence 2020

    Fracture Liaison Service at an Academic Center with an Open Health System: 30-month Outcomes

    Donna Jose1, Micah Yu2, Karina Torralba3, Christina Downey4, Justin Dunn5 and Vinicius Cabido5, 1Loma Linda University Medical Center, Ontario, CA, 2Loma Linda University Medical Center, Loma Linda, CA, 3Loma Linda University School of Medicine, Redlands, CA, 4Loma Linda University Medical Center, Redlands, CA, 5Loma Linda University Medical Center, Loma Linda

    Background/Purpose: Osteoporosis causes significant morbidity, mortality and healthcare burden. There continues to be a care gap in osteoporosis recognition, treatment and prevention. Several healthcare systems…
  • 1
  • 2
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences